Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 2Brain Neoplasms 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Has results × Lacosamide × Clear all
NCT03436433 2023-04-13

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

Duke University

Phase 2 Terminated
4 enrolled 8 charts
CNS

Brain Neoplasms, Glioma

NCT01432171 2018-12-19

Lacosamide in Preventing Seizures in Participants With Malignant Glioma

M.D. Anderson Cancer Center

Phase NA Terminated
37 enrolled 11 charts
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡